Cargando…

Safety, biodistribution and radiation dosimetry of [(123)I]ioflupane in healthy Chinese volunteers

BACKGROUND: [(123)I]ioflupane is a radiopharmaceutical used to visualise the dopaminergic neuron terminals in the striata, to aid in the differential diagnosis among Parkinsonian syndromes (e.g., Parkinson’s disease). However, nearly all of the subjects in the initial development studies of [(123)I]...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Min, Wang, Yue, Wang, Jin, Li, Xiang, Li, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082142/ https://www.ncbi.nlm.nih.gov/pubmed/37029298 http://dx.doi.org/10.1186/s13550-023-00978-3

Ejemplares similares

The clinical safety, biodistribution and internal radiation dosimetry of [(18)F]AH113804 in healthy adult volunteers
por: Somer, E. J., et al.
Publicado: (2016)

Safety, Biodistribution, and Radiation Dosimetry of (18)F-rhPSMA-7.3 in Healthy Adult Volunteers
por: Tolvanen, Tuula, et al.
Publicado: (2021)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol ((18)F) injection in healthy Japanese adult volunteers
por: Senda, Michio, et al.
Publicado: (2015)

Biodistribution and radiation dosimetry of [(64)Cu]copper dichloride: first-in-human study in healthy volunteers
por: Avila-Rodriguez, M.A., et al.
Publicado: (2017)

Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging
por: Covington, Matthew F., et al.
Publicado: (2015)

Interpreting (123)I–ioflupane dopamine transporter scans using hybrid scores
por: Nichols, Kenneth J., et al.
Publicado: (2018)

Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses
por: Badoud, Simon, et al.
Publicado: (2016)

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

Rest Tremor Pattern Predicts DaTscan ( (123)I‐Ioflupane) Result in Tremulous Disorders
por: Quattrone, Andrea, et al.
Publicado: (2021)

First-in-human study of a novel cell death tracer [(99m)Tc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers
por: Metelerkamp Cappenberg, Taco, et al.
Publicado: (2023)

Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Correction: Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Accumulation of (123)I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Diagnostic Effectiveness of [(123)I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease
por: ASAHI, Takashi, et al.
Publicado: (2016)

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials
por: O'Brien, John T, et al.
Publicado: (2014)

Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
por: Castillo-Barnes, Diego, et al.
Publicado: (2018)

Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy
por: Sato, Kenichiro, et al.
Publicado: (2016)

Phase I study to assess safety, biodistribution and radiation dosimetry for (89)Zr-girentuximab in patients with renal cell carcinoma
por: Merkx, Robin I. J., et al.
Publicado: (2021)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Clinical Comparison of (99m)Tc Exametazime and (123)I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury
por: Newberg, Andrew B., et al.
Publicado: (2014)

Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [(18)F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease
por: Wang, Ying, et al.
Publicado: (2022)

Biodistribution and radiation dosimetry of (11)C-labelled docetaxel in cancer patients
por: van der Veldt, Astrid A. M., et al.
Publicado: (2010)

Clinical translation of (18)F-fluoropivalate – a PET tracer for imaging short-chain fatty acid metabolism: safety, biodistribution, and dosimetry in fed and fasted healthy volunteers
por: Dubash, Suraiya R., et al.
Publicado: (2020)

Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography
por: Li, Lianghua, et al.
Publicado: (2023)

Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning
por: Nakajima, Kenichi, et al.
Publicado: (2022)

Biodistribution and radiodosimetry of a novel myocardial perfusion tracer (123)I-CMICE-013 in healthy rats
por: Duan, Yin, et al.
Publicado: (2014)

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021)

Prospective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients
por: Wang, Zhe, et al.
Publicado: (2015)

Follow-Up Findings in Multiple System Atrophy from [(123)I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway
por: Schwarzenberg, Johannes, et al.
Publicado: (2010)

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
por: Murakami, Hidetomo, et al.
Publicado: (2018)

Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [(11)C]K-2, in healthy human subjects
por: Hatano, Mai, et al.
Publicado: (2021)

Human biodistribution and radiation dosimetry of the demyelination tracer [(18)F]3F4AP
por: Brugarolas, Pedro, et al.
Publicado: (2022)

Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborate
por: Marti-Climent, J. M., et al.
Publicado: (2015)

Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers: Safety and Pharmacokinetics of Single or Multiple Intravenous Infusions
por: Li, Hao, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7ffgduhmr6d7tr7354l915vtu4